
NYSE:HCA
This summary was created by AI, based on 2 opinions in the last 12 months.
HCA Healthcare has garnered positive reviews from experts, highlighting its efficient management and the vital services it provides. One reviewer noted a strong inclination towards the company's operational efficiency, particularly its outpatient services, which he utilizes personally. Additionally, the company has demonstrated impressive financial performance, achieving a remarkable 628% increase over the past decade and consistently reaching new all-time highs, reflecting strong market confidence. The company has also been proactively buying back its shares, resulting in a substantial reduction of 44% since the end of 2015, which suggests a strategic approach to shareholder value enhancement. Overall, HCA Healthcare appears to be in a favorable position within the healthcare sector, garnering a mixture of operational success and strong market performance.
He's been recommending this post-Covid, because it's been benefitting from the huge bounce back in medical procedures that were delayed. HCA just made a new all-time high. But last Friday it reported a shocking top and bottom line miss. Is down 13% in the past week, but this is an opportunity. HCA missed only slightly, not the end of the world. Hurricanes hit revenues by $200-300 million and 60-90 cents per share, a one-off impact. HCA reaffirmed its full-year forecast, though
(A Top Pick Aug 13/15. Down 11.51%.) This has been dead quiet over the course of the last year. It had a lift through November-February, and then basically has consolidated ever since. The group is actually starting to look quite interesting. The sector has been improving from a relative strength standpoint, since June. This could still be a Buy at these levels.
HCA Healthcare is a American stock, trading under the symbol HCA (previously HCA-N on Stockchase) on the New York Stock Exchange (HCA). It is usually referred to as NYSE:HCA or HCA
In the last year, 2 stock analysts issued a Buy, Sell, or Hold rating on HCA (previously HCA-N on Stockchase). 2 analysts recommended to BUY and 0 analysts recommended to SELL the stock. The latest stock analyst rating is BUY. Read the latest stock experts' ratings for HCA Healthcare.
HCA Healthcare was recommended as a Top Pick by Richard Fogler on 2026-04-27. Read the latest stock experts ratings for HCA Healthcare.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for HCA Healthcare.
HCA Healthcare is followed by 17 investors on Stockchase and is a trending stock that is worth watching.
On 2026-09-04, HCA Healthcare (HCA) stock closed at a price of $405.00.
He likes it a lot. It is very well run and provides needed services with positive trends happening for these services. It has a big outpatient component which he uses himself.